Rickets, Vitamin‑D‑Dependent

Overview

Rickets, vitamin‑D‑dependent (sometimes called hereditary or familial rickets) is a rare genetic disorder that impairs the body’s ability to activate or respond to vitamin D, leading to insufficient calcium and phosphate for normal bone mineralisation. Unlike nutritional rickets, which is usually caused by inadequate vitamin D intake or sunlight exposure, the vitamin‑D‑dependent form is inherited in an autosomal‑recessive pattern and may present despite adequate dietary intake.

Both children and, less commonly, adults can be affected. The condition is most frequently diagnosed in infants or toddlers because the rapid growth of the skeleton unmasks the mineral deficiency early. The exact prevalence is unclear, but estimates suggest 1 in 100,000 – 200,000 live births worldwide, with higher case concentrations in populations where consanguineous marriages are common.

Key organizations such as the CDC, Mayo Clinic, and the NIH recognise vitamin‑D‑dependent rickets (VDDR) as a distinct clinical entity requiring specific genetic testing for confirmation.

Symptoms

The clinical picture varies with the severity of the enzymatic defect and the age at presentation. Common symptoms include:

• Bone pain and tenderness – especially in the lower limbs and ribs.
• Delayed motor milestones – difficulty standing, walking, or crawling.
• Growth retardation – height below the 3rd percentile for age.
• Muscle weakness – leading to frequent falls.
• Rachitic rosary – bead‑like enlargements of the costochondral junctions.
• Craniotabes – softening of the skull bones, sometimes visible as a palpable “crack” on percussion.
• Leg deformities – genu varum (bow‑legs) or genu valgum (knock‑knees) caused by weakened weight‑bearing bones.
• Dental abnormalities – delayed tooth eruption, enamel hypoplasia, or tooth loss.
• Hypocalcemic seizures – rare but serious, resulting from low serum calcium levels.
• Enlarged wrists and ankles – due to widened growth plates.

In adults with untreated disease, symptoms may progress to osteomalacia (softening of adult bones), chronic bone pain, and increased fracture risk.

Causes and Risk Factors

Vitamin‑D‑dependent rickets is caused by mutations that disrupt the normal metabolism or signalling of vitamin D. The two primary genetic subtypes are:

VDDR‑1A (Pseudo‑hypoparathyroidism)

• Mutation in the CYP27B1 gene encoding 1‑α‑hydroxylase, the enzyme that converts 25‑hydroxyvitamin D (25‑OH‑D) to the active form 1,25‑dihydroxyvitamin D (calcitriol).

VDDR‑1B (Vitamin‑D‑dependent rickets type 2)

• Mutation in the VDR gene encoding the vitamin D receptor, rendering tissues unresponsive to calcitriol.

Risk factors are largely genetic:

• Consanguineous parentage (e.g., first‑cousin marriages) increases the chance of inheriting two defective alleles.
• Families with a known history of VDDR.
• Ethnic groups with higher rates of specific mutations (e.g., certain Middle‑Eastern or South‑Asian populations).

Environmental factors such as low sunlight or poor nutrition do not cause VDDR, but they can worsen the clinical picture if the underlying defect is present.

Diagnosis

Diagnosing vitamin‑D‑dependent rickets requires a systematic approach that combines clinical findings, biochemical testing, imaging, and genetic analysis.

Laboratory Tests

• Serum calcium – often low or low‑normal.
• Serum phosphate – typically low.
• Alkaline phosphatase (ALP) – markedly elevated due to increased osteoblastic activity.
• Parathyroid hormone (PTH) – elevated in VDDR‑1A (secondary hyperparathyroidism) and normal or low in VDDR‑1B.
• 25‑hydroxyvitamin D – usually normal or high, distinguishing VDDR from nutritional rickets.
• 1,25‑dihydroxyvitamin D – low in VDDR‑1A, high or normal in VDDR‑1B.

Imaging

• Radiographs of wrists, knees, and pelvis reveal widening of growth plates, metaphyseal cupping, and frayed trabeculae.
• Bone densitometry (DEXA) may show decreased bone mineral density.

Genetic Testing

Sequencing of CYP27B1 and VDR genes confirms the diagnosis, guides treatment (e.g., high‑dose calcitriol works for VDDR‑1A but not VDDR‑1B), and enables carrier testing for family members.

Differential Diagnosis

Conditions that can mimic VDDR include nutritional rickets, hypophosphatemic rickets, renal tubular acidosis, and certain metabolic bone diseases. Careful lab interpretation and genetic testing help separate these entities.

Treatment Options

Therapy aims to bypass the metabolic block, normalise calcium/phosphate balance, and promote proper bone mineralisation.

Medication

• Calcitriol (1,25‑dihydroxyvitamin D) – the mainstay for VDDR‑1A. Doses range from 0.03 µg/kg/day to higher regimens, titrated to maintain serum calcium in the low‑normal range and suppress PTH.
• High‑dose oral vitamin D₃ (cholecalciferol) – sometimes used in VDDR‑1B to achieve supraphysiologic serum 25‑OH‑D levels, though response is limited because the receptor is defective.
• Calcium supplementation – usually 500–1000 mg elemental calcium per day, divided into two doses, to ensure adequate substrate for mineralisation.
• Phosphate salts – may be needed in VDDR‑1B or when serum phosphate remains low despite calcitriol.
• Bisphosphonates – rarely employed for severe bone pain or to control rapid bone turnover, under specialist supervision.

Procedures

• Orthopedic correction – surgical intervention (e.g., guided growth plates, osteotomies) for persistent leg deformities after biochemical control is achieved.
• Dental care – regular dental monitoring; extraction of severely malformed teeth if required.

Lifestyle & Supportive Measures

• Regular weight‑bearing activity (walking, age‑appropriate play) to stimulate bone strength.
• Adequate dietary calcium (e.g., milk, fortified plant milks, leafy greens) tailored to age‑specific needs.
• Sunlight exposure of 10‑15 minutes per day on face and arms when feasible, recognizing it will not replace medical therapy in VDDR.

Living with Rickets, Vitamin‑D‑Dependent

Managing VDDR is a lifelong process that involves medical follow‑up, self‑monitoring, and community support.

Daily Management Tips

• Medication adherence – Use a pill organizer or set alarms; never skip doses without consulting the endocrinologist.
• Blood test schedule – Serum calcium, phosphate, ALP, and PTH are typically checked every 3‑6 months in growing children, then annually in stable adults.
• Growth monitoring – Plot height and weight on a growth chart at each pediatric visit.
• Physical activity – Encourage low‑impact sports (swimming, cycling) that promote muscle strength without excessive stress on vulnerable bones.
• Nutrition – Aim for age‑appropriate calcium intake (e.g., 1,000 mg/day for children 1‑3 years; 1,300 mg/day for adolescents).
• School accommodations – Inform teachers about the condition; allow for short breaks if fatigue or pain occurs.
• Psychosocial support – Connect with patient advocacy groups (e.g., National Organization for Rare Disorders) for counseling and peer networking.

Follow‑up Care

Regular visits to a pediatric endocrinologist or metabolic bone specialist are essential. Adjustments to calcitriol or calcium doses are often required during periods of rapid growth, illness, or changes in diet.

Prevention

Because VDDR is genetic, primary prevention is not possible in the same way as nutritional rickets. However, families can take steps to reduce the impact on future generations:

• Genetic counseling – Recommended for couples with a known carrier status or a family history of VDDR.
• Carrier testing – Available for at‑risk relatives; results guide reproductive decisions.
• Avoidance of consanguineous unions – Reduces the likelihood of inheriting two defective alleles.
• Early newborn screening – In regions where VDDR prevalence is higher, targeted screening can identify affected infants before symptoms develop.

Complications

If untreated or inadequately treated, vitamin‑D‑dependent rickets can lead to serious sequelae:

• Severe bone deformities – Permanent bow‑legs, knock‑knees, or spinal curvature (scoliosis).
• Growth failure – Final adult height markedly below genetic potential.
• Fractures – Pathologic fractures from weakened bone.
• Hypocalcemic seizures – Potentially life‑threatening.
• Cardiovascular calcifications – Rare, but high‑dose calcium therapy without monitoring can promote ectopic calcification.
• Dental loss – Early tooth decay and loss affecting nutrition and self‑esteem.

When to Seek Emergency Care

Key Take‑aways

Vitamin‑D‑dependent rickets is a rare but treatable genetic disorder. Early recognition, accurate genetic diagnosis, and lifelong hormone‑replacement therapy can allow affected individuals to lead active, healthy lives. Continuous monitoring, patient education, and family counseling are essential components of comprehensive care.

For more detailed information, consult reputable sources such as the Mayo Clinic, the CDC, and the NIH.